| scholarly article | Q13442814 |
| P2093 | author name string | Garry M Steil | |
| Gayane Voskanyan | |||
| Sami S Kanderian | |||
| Stu Weinzimer | |||
| P2860 | cites work | A physiological model of glucose-insulin interaction in type 1 diabetes mellitus | Q28250044 |
| In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes | Q30439654 | ||
| Retrospective pilot feedback survey of 200 users of the AIDA Version 4 Educational Diabetes Program. 1--Quantitative Survey Data | Q31046709 | ||
| A model of the kinetics of insulin in man. | Q34518150 | ||
| Closed-loop insulin delivery-the path to physiological glucose control | Q35637319 | ||
| The dawn phenomenon revisited: implications for diabetes therapy | Q36201952 | ||
| Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy | Q37067084 | ||
| Assessment of insulin sensitivity in vivo | Q39816379 | ||
| An adaptive input-output modeling approach for predicting the glycemia of critically ill patients. | Q40281022 | ||
| Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. | Q40480952 | ||
| Quantitative estimation of insulin sensitivity | Q41600825 | ||
| Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects | Q41689577 | ||
| Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia | Q42480892 | ||
| The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects | Q42499127 | ||
| Feasibility of automating insulin delivery for the treatment of type 1 diabetes | Q42604696 | ||
| Mathematical modeling research to support the development of automated insulin-delivery systems | Q42607729 | ||
| Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system | Q42689631 | ||
| Modeling insulin action for development of a closed-loop artificial pancreas | Q44184886 | ||
| Determination of Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor | Q44426115 | ||
| Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects | Q44686546 | ||
| Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test | Q44865466 | ||
| Effect of carbohydrate source on post-prandial blood glucose in subjects with type 1 diabetes treated with insulin lispro | Q44910871 | ||
| Morning insulin requirements. Critique of dawn and meal phenomena | Q45020366 | ||
| Evaluation of glucose controllers in virtual environment: methodology and sample application | Q45142557 | ||
| In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop | Q45175373 | ||
| Extracellular glucose distribution is not altered by insulin: analysis of plasma and interstitial L-glucose kinetics | Q46330312 | ||
| Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 | ||
| Assessment of extracellular glucose distribution and glucose transport activity in conscious rats | Q46450240 | ||
| Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system | Q46460184 | ||
| Targeted glycemic reduction in critical care using closed-loop control | Q46460195 | ||
| A simulation model of glucose regulation in the critically ill. | Q46473073 | ||
| Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas | Q46770123 | ||
| Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions | Q46868324 | ||
| Model-based insulin and nutrition administration for tight glycaemic control in critical care. | Q46917026 | ||
| A minimal model for glycemia control in critically ill patients | Q46942570 | ||
| Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes | Q46972127 | ||
| KADIS--a computer-aided decision support system for improving the management of type-I diabetes | Q48903586 | ||
| Modeling the insulin-glucose system in man. | Q54568113 | ||
| A model-based system for the individual prediction of metabolic responses to improve therapy in type I diabetes | Q68650618 | ||
| Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes | Q70633918 | ||
| Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production | Q71215529 | ||
| Outpatient assessment of Karlsburg Diabetes Management System-based decision support | Q80236880 | ||
| P433 | issue | 5 | |
| P921 | main subject | glucose | Q37525 |
| type-1 diabetes | Q124407 | ||
| P304 | page(s) | 1047-1057 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Journal of Diabetes Science and Technology | Q15755249 |
| P1476 | title | Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes | |
| P478 | volume | 3 |
| Q50421430 | A Neural-Network-Based Approach to Personalize Insulin Bolus Calculation Using Continuous Glucose Monitoring. |
| Q41848729 | A composite model of glucagon-glucose dynamics for in silico testing of bihormonal glucose controllers |
| Q30409801 | Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative control |
| Q39404956 | An Adaptive Nonlinear Basal-Bolus Calculator for Patients With Type 1 Diabetes. |
| Q36366704 | Bolus Estimation--Rethinking the Effect of Meal Fat Content |
| Q27008127 | Closed-loop insulin delivery for treatment of type 1 diabetes |
| Q30424297 | Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery |
| Q37846089 | Closed-loop insulin delivery: from bench to clinical practice |
| Q36560323 | Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial |
| Q57164675 | Control Limitations in Models of T1DM and the Robustness of Optimal Insulin Delivery |
| Q30434551 | Diabetes: Models, Signals, and Control |
| Q56334391 | Identifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems |
| Q39438160 | Model identification using stochastic differential equation grey-box models in diabetes |
| Q88131429 | Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies |
| Q42125623 | Predicting Plasma Glucose From Interstitial Glucose Observations Using Bayesian Methods |
| Q42599316 | Progress in development of an artificial pancreas |
| Q49943525 | The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day. |
| Q34894471 | The effect of insulin feedback on closed loop glucose control |
| Q30422229 | The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results |
| Q42735600 | Update on mathematical modeling research to support the development of automated insulin delivery systems |
| Q34209110 | Use of Subcutaneous Interstitial Fluid Glucose to Estimate Blood Glucose: Revisiting Delay and Sensor Offset |
| Q30416614 | Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller |
Search more.